Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAltitude Group Regulatory News (ALT)

Share Price Information for Altitude Group (ALT)

Share Price is delayed by 15 minutes
Get Live Data
20.50    0.50 (2.50%)
Bid:
20.00
Ask:
21.00
Spread: 1.00 (5.00%)
Market Cap: £14.99m
ALT Live PriceLast checked at - London Stock Exchange

Intraday Altitude Group Share Chart

Re Long Term Incentive Plan

11 May 2007 10:38

Dowlis Corporate Solutions plc11 May 2007 Date: 11th May 2007On behalf of: Dowlis Corporate Solutions plc ("Dowlis" or "the Company") Immediate Release Dowlis Corporate Solutions plcApproval of Long Term Incentive Plan ("LTIP") Dowlis Corporate Solutions plc, the marketing, information and logisticssolutions business, is pleased to announce the approval of a Long Term IncentivePlan for its Finance Director and other senior directors. The LTIP was approvedby the Board of Directors today on the recommendation of the Company'sremuneration committee who have, over the last six months, undertaken acomprehensive review of alternative incentive arrangements for the Company'sexisting senior executive team and to attract and retain high calibre employeesin the future. As set out in the 2006 Annual Report, this is to take the form of a long termincentive plan under which awards will be made annually for growth inshareholder value in excess of a base target over the ensuing three years. TheCompany believes that the LTIP rules are consistent with the ABI Guidelines forExecutive Remuneration. Under the Company's articles, the LTIP does not requireshareholder approval. Key points: • The first award under the long term incentive plan will allowparticipants to share in a total "pool" amounting to 5% of the increase inshareholder value above the base target. Main Board Director Barrett Bedrossianwill have 15% of this pool, the remainder will be for other senior managers. • In the first two years of the plan, until such time as there arethree long term incentive plan awards in place, it will be augmented by thegrant of nil-cost options (EMI options to the extent possible) to the sameparticipants, the exercise of which is dependant upon the share price reachingagreed target levels • The grant of options, to augment the long term incentive above, areexercisable dependant upon the share price reaching 60p and 75p for 30consecutive dealing days each, with 50% of the conditional grant being made uponreaching each of these targets. In total, options over up to 930,000 shares maybe issued if both targets are met. Following the above transaction, Barrett Bedrossian will be awarded options overa maximum of 140,000 Ordinary Shares, the acquisition of which is conditional onthe satisfaction of performance conditions. A copy of the LTIP Rules is available to shareholders upon request from theCompany's registered office. Enquiries: Dowlis Corporate Solutions plc www.dowlis.comMartin Varley (Chief Executive)/Barrett Bedrossian 0870 224 6677(Finance Director) Redleaf CommunicationsEmma Kane/Sanna Lehtinen 020 7822 0200 Daniel Stewart & Company plcLindsay Mair / Tom Jenkins 020 7776 6550 Zeus CapitalAlex Clarkson 0161 831 1512 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th Jun 20267:00 amRNSDirector/PDMR Shareholding
1st Jun 20268:31 amRNSExercise & Grant of Options and TVR
17th Apr 20267:00 amRNSBoard Role Change
14th Apr 20263:25 pmRNSDirector/PDMR Dealing
9th Apr 202612:00 pmRNSDirector/PDMR Dealing
31st Mar 20267:00 amRNSTrading Update
5th Mar 20263:39 pmRNSDirector/PDMR Shareholding
5th Mar 20267:00 amRNSAppointment of Independent Non-Executive Director
10th Feb 202612:32 pmRNS-RAppointment of Chief Commercial Officer
4th Feb 20267:00 amRNSAppointment of Nominated Adviser and Sole Broker
19th Jan 20261:33 pmRNSPDMR Dealing
23rd Dec 20257:00 amRNSPDMR Dealing
23rd Dec 20257:00 amRNSPDMR Dealing
1st Dec 20259:01 amRNSPDMR Dealing
28th Nov 20257:00 amRNSChange of Registered Office
27th Nov 20254:57 pmRNSCorrection: Exercise & Grant of Options and TVR
27th Nov 20257:30 amRNSExercise & Grant of Options, PDMR Dealings and TVR
27th Nov 20257:00 amRNSInterim Results
11th Nov 20257:00 amRNSTrading Update, Board Change and Notice of Results
30th Oct 20257:00 amRNSHolding(s) in Company
26th Sep 20257:00 amRNSResult of AGM
12th Sep 20257:00 amRNSDirector/PDMR Dealing
11th Sep 20257:00 amRNSDirector/PDMR Dealing
10th Sep 20257:00 amRNSDirector/PDMR Dealing
8th Sep 20257:00 amRNSDirector/PDMR Dealing
5th Sep 20257:00 amRNSDirector/PDMR Dealing
15th Aug 20254:20 pmRNSChange of Venue for the 2025 AGM
7th Aug 20257:00 amRNSAudited Annual Results and Notice of AGM
30th Jul 20257:00 amRNSNotice of Results
15th Jul 20257:00 amRNSBoard Changes and Trading Update
23rd Jun 20257:00 amRNSAppointment of CFO
17th Jun 20257:00 amRNSBoard Change and Trading Update
15th May 20257:00 amRNSGrant of Options and PDMR Dealings
9th May 20255:50 pmRNSDirector/PDMR Dealing
9th Apr 20257:00 amRNSExercise of Options, Director Dealings and TVR
1st Apr 20257:00 amRNSDirector/PDMR Dealing
31st Mar 20257:00 amRNSTrading Update and New University Contract Awards
28th Mar 20257:00 amRNSChange of Registered Office
11th Mar 20257:00 amRNSDirector/PDMR Dealings
6th Mar 20257:00 amRNSDirectorate Change
3rd Dec 20247:00 amRNSInterim Results
15th Nov 20247:00 amRNSTrading Update and Notice of Results
8th Oct 20244:04 pmRNSHolding(s) in Company
23rd Sep 20244:47 pmRNSResult of AGM
6th Sep 202412:30 pmRNSPosting of Annual Report and Notice of AGM
30th Jul 20247:00 amRNSAudited Annual Results and Notice of AGM
23rd Jul 20247:00 amRNSFull Year Trading Update
3rd Jun 20249:28 amRNSExercise of Options, Director Dealings and TVR
20th May 20247:00 amRNSGrant of Options and PDMR Dealings
1st May 20247:00 amRNSPre-Close Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.